ArticleJournal of managed care & specialty pharmacy2025
Health care resource utilization and costs in Medicare Advantage beneficiaries using glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter-2 inhibitors.
Insiya B Poonawalla et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.